Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis

Hdl Handle:
http://hdl.handle.net/10144/336363
Title:
Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis
Authors:
Ford, Nathan; Calmy, Alexandra; Andrieux-Meyer, Isabelle; Hargreaves, Sally; Mills, Edward J; Shubber, Zara
Journal:
AIDS (London, England)
Abstract:
The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregnant women. We conducted a systematic review and meta-analysis of severe adverse events in HIV-positive women who initiated NVP while pregnant.
Affiliation:
Médecins Sans Frontières, Geneva, Switzerland. nathan.ford@msf.org
Publisher:
Lippincott Williams & Wilkins
Issue Date:
24-Apr-2013
URI:
http://hdl.handle.net/10144/336363
DOI:
10.1097/QAD.0b013e32835e0752
PubMed ID:
23299174
Language:
en
ISSN:
1473-5571
Appears in Collections:
Womens/Reproductive Health

Full metadata record

DC FieldValue Language
dc.contributor.authorFord, Nathanen_GB
dc.contributor.authorCalmy, Alexandraen_GB
dc.contributor.authorAndrieux-Meyer, Isabelleen_GB
dc.contributor.authorHargreaves, Sallyen_GB
dc.contributor.authorMills, Edward Jen_GB
dc.contributor.authorShubber, Zaraen_GB
dc.date.accessioned2014-11-30T16:27:42Z-
dc.date.available2014-11-30T16:27:42Z-
dc.date.issued2013-04-24-
dc.identifier.citationAdverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. 2013, 27 (7):1135-43 AIDSen_GB
dc.identifier.issn1473-5571-
dc.identifier.pmid23299174-
dc.identifier.doi10.1097/QAD.0b013e32835e0752-
dc.identifier.urihttp://hdl.handle.net/10144/336363-
dc.description.abstractThe risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregnant women. We conducted a systematic review and meta-analysis of severe adverse events in HIV-positive women who initiated NVP while pregnant.en_GB
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen_GB
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren_GB
dc.subjectHIV/AIDSen_GB
dc.subjectMaternal Care/Women's Healthen_GB
dc.subject.meshAdulten_GB
dc.subject.meshAnti-HIV Agentsen_GB
dc.subject.meshCD4 Lymphocyte Counten_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHIV Seropositivityen_GB
dc.subject.meshHumansen_GB
dc.subject.meshNevirapineen_GB
dc.subject.meshPregnancyen_GB
dc.subject.meshPregnancy Complications, Infectiousen_GB
dc.subject.meshRisk Assessmenten_GB
dc.titleAdverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysisen
dc.contributor.departmentMédecins Sans Frontières, Geneva, Switzerland. nathan.ford@msf.orgen_GB
dc.identifier.journalAIDS (London, England)en_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.